vidarabine has been researched along with Osteosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ball, ED; Bashey, A; Broome, HE; Carrier, E; Hoh, CK; Holman, P; Lane, T; Sun, C; Tanner, ML | 1 |
1 other study(ies) available for vidarabine and Osteosclerosis
Article | Year |
---|---|
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Osteosclerosis; Primary Myelofibrosis; Radionuclide Imaging; Remission Induction; Splenomegaly; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2003 |